Pharmarise Holdings (TSE:2796) COGS-to-Revenue : 0.86 (As of May. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Pharmarise Holdings COGS-to-Revenue?

Pharmarise Holdings's Cost of Goods Sold for the three months ended in May. 2024 was 円11,798 Mil. Its Revenue for the three months ended in May. 2024 was 円13,792 Mil.

Pharmarise Holdings's COGS to Revenue for the three months ended in May. 2024 was 0.86.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Pharmarise Holdings's Gross Margin % for the three months ended in May. 2024 was 14.46%.

Pharmarise Holdings COGS-to-Revenue Historical Data

The historical data trend for Pharmarise Holdings's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmarise Holdings COGS-to-Revenue Chart

Pharmarise Holdings Annual Data

Trend

May15

May16

May17

May18

May19

May20

May21

May22

May23

May24

COGS-to-Revenue

Get a 7-Day Free Trial

0.85

0.84

Pharmarise Holdings Quarterly Data
	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24
COGS-to-Revenue	Get a 7-Day Free Trial															0.84	0.84	0.84	0.84	0.86

Pharmarise Holdings COGS-to-Revenue Calculation

Pharmarise Holdings's COGS to Revenue for the fiscal year that ended in May. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	46017	/	54466
	=	0.84

Pharmarise Holdings's COGS to Revenue for the quarter that ended in May. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	11798	/	13792
	=	0.86

Pharmarise Holdings (TSE:2796) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Pharmarise Holdings's Gross Margin % for the three months ended in May. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	11798 / 13792
	=	14.46 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Pharmarise Holdings COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Pharmarise Holdings's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmarise Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pharmarise Holdings Corp (TSE:2796) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

8 Floor, Sumitomo Nakano Sakue Building, 1-38-1 Chuo, Nakano-ku, Tokyo, JPN, 164-0011

Website

http://www.pharmarise.com

Pharmarise Holdings Corp is engaged in the operation of dispensing pharmacies, which prescribe medicines to general patients based on prescriptions issued by medical institutions. It is also engaged in the storage and management of medical examination records of patients on behalf of the medical institution.

Pharmarise Holdings Headlines

No Headlines